High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  European Heart Journal

• Publication date

  2007-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/EURHEARTJ/EHM062PMID 17409111
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Effect of CETP -629C>A Promoter Polymorphism on HDL Cholesterol is Dependent on Serum Triglycerides.

  2005cited by this paper
• Cholesteryl Ester Transfer Protein Directly Mediates Selective Uptake of High Density Lipoprotein Cholesteryl Esters by the Liver

  2005cited by this paper
• The effect of cholesteryl ester transfer protein -629C->A promoter polymorphism on high-density lipoprotein cholesterol is dependent on serum triglycerides.

  2005cited by this paper
• Plasma cholesteryl ester transfer is a determinant of intima-media thickness in type 2 diabetic and nondiabetic subjects: role of CETP and triglycerides.

  2005cited by this paper
• Cholesteryl Ester Transfer Protein TaqIB Variant, High-Density Lipoprotein Cholesterol Levels, Cardiovascular Risk, and Efficacy of Pravastatin Treatment: Individual Patient Meta-Analysis of 13 677 Subjects

  2005cited by this paper
• Lipid transfer proteins (LTP) and atherosclerosis.

  2005cited by this paper
• CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease.

  2005cited by this paper
• Raising High-Density Lipoprotein in Humans Through Inhibition of Cholesteryl Ester Transfer Protein: An Initial Multidose Study of Torcetrapib

  2004cited by this paper
• Plasma Levels of Cholesteryl Ester Transfer Protein and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women: The Prospective EPIC (European Prospective Investigation into Cancer and nutrition)–Norfolk Population Study

  2004cited by this paper
• Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.M300511-JLR200

  2004cited by this paper
• A review of CETP and its relation to atherosclerosis Published, JLR Papers in Press, September 1, 2004. DOI 10.1194/jlr.R400007-JLR200

  2004cited by this paper
• Alterations in high‐density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins

  2003cited by this paper
• Importance of different pathways of cellular cholesterol efflux.

  2003cited by this paper
• Efficacy and Safety of a Novel Cholesteryl Ester Transfer Protein Inhibitor, JTT-705, in Humans: A Randomized Phase II Dose-Response Study

  2002cited by this paper
• A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.

  2002cited by this paper
• Evolution of methods for measurement of HDL-cholesterol: from ultracentrifugation to homogeneous assays.

  2001cited by this paper
• Lipid transfer protein activities in type 1 diabetic patients without renal failure and nondiabetic control subjects and their association with coronary artery calcification.

  2001cited by this paper
• Expression of cholesteryl ester transfer protein in human atherosclerotic lesions and its implication in reverse cholesterol transport.

  2001cited by this paper
• Urinary Albumin Excretion is Associated with Renal Functional Abnormalities in a Non- diabetic Population

  2001cited by this paper
• Lack of association of the common TaqIB polymorphism in the cholesteryl ester transfer protein gene with angiographically assessed coronary atherosclerosis

  2001cited by this paper
• Effect of intensive lipid-lowering strategy on low-density lipoprotein particle size in patients with type 2 diabetes mellitus.

  2001cited by this paper
• Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population.

  2000cited by this paper
• Comparison of Laboratory Parameters as Risk Factors for the Presence and the Extent of Coronary or Carotid Atherosclerosis: the Significance of Apolipoprotein B to Apolipoprotein AII Ratio

  2000cited by this paper
• Remodelling of high density lipoproteins by plasma factors.

  1999cited by this paper
• Determinants of plasma HDL-cholesterol in hypertriglyceridemic patients. Role of cholesterol-ester transfer protein and lecithin cholesteryl acyl transferase.

  1997cited by this paper
• Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.

  1997cited by this paper
• Cholesteryl ester transfer protein: friend or foe?

  1996cited by this paper
• Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels.

  1996cited by this paper
• Molecular physiology of reverse cholesterol transport.

  1995cited by this paper
• Reference Limits of Apolipoprotein A-I and Apolipoprotein B Using an IFCC Standardized Immunonephelometric Method

  1995cited by this paper
• Cholesteryl ester transfer proteins, reverse cholesterol transport, and atherosclerosis

  1995cited by this paper
• Plasma cholesteryl ester transfer protein.

  1993cited by this paper
• High-density lipoproteins and reverse cholesterol transport

  1993cited by this paper
• Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables.

  1991cited by this paper
• Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia.

  1991cited by this paper
• Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.

  1990cited by this paper
• Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects.

  1990cited by this paper
• Cholesteryl Ester Transfer Protein : Friend or Foe ? Editorial

  year unknowncited by this paper

• Associations of Multimarkers of Metabolic Malnutrition and Inflammation With All‐Cause Mortality and Their Interplay With Thyroid Function

  2026cites this paper
• Associations of high-density lipoprotein cholesterol, particles and subspecies with the risk of hypertension: findings from the PREVEND prospective study

  2025cites this paper
• High-density lipoprotein cholesterol, particles and subspecies and the risk of chronic kidney disease: The PREVEND prospective study

  2025cites this paper
• Self-reported smoking, urine cotinine, and risk of incident hypertension: findings from the PREVEND prospective cohort study

  2025cites this paper
• Alcohol Consumption, High-Density Lipoprotein Particles and Subspecies, and Risk of Cardiovascular Disease: Findings from the PREVEND Prospective Study

  2024cites this paper
• Urine cotinine versus self-reported smoking and the risk of chronic kidney disease

  2024cites this paper
• Self-reported smoking, urine cotinine, and risk of type 2 diabetes: Findings from the PREVEND prospective cohort study.

  2024cites this paper
• CETP expression ameliorates endothelial function in female mice through estrogen receptor-α and endothelial nitric oxide synthase pathway.

  2023cites this paper
• Self-reported alcohol consumption, carbohydrate deficient transferrin and risk of cardiovascular disease: the PREVEND prospective cohort study.

  2021cites this paper
• The Association between HDL-C and Subclinical Atherosclerosis Depends on CETP Plasma Concentration: Insights from the IMPROVE Study

  2021cites this paper
• High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events

  2021cites this paper
• Cholesteryl Ester Transfer Protein Impairs Triglyceride Clearance via Androgen Receptor in Male Mice

  2020cites this paper
• Administration of eicosapentaenoic acid may alter high-density lipoprotein heterogeneity in statin-treated patients with stable coronary artery disease: A 6-month randomized trial.

  2020cites this paper
• Vitamin B6, Inflammation, and Cardiovascular Outcome in a Population-Based Cohort: The Prevention of Renal and Vascular End-Stage Disease (PREVEND) Study

  2020cites this paper
• HDL (High-Density Lipoprotein) Cholesterol Efflux Capacity Is Associated With Incident Cardiovascular Disease in the General Population.

  2019cites this paper
• Dullaart, R. P. F. (2019). Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization

  2019cites this paper
• Circulating total bilirubin and risk of non-alcoholic fatty liver disease in the PREVEND study: observational findings and a Mendelian randomization study

  2019cites this paper
• Correlation of serum cholestryl ester transfer protein (CETP) level with lipid profile in young myocardial infarction patients

  2019cites this paper
• Association of Serum Cholesterol Ester Transfer Protein Levels with Taq IB Polymorphism in Acute Coronary Syndrome.

  2019cites this paper
• Self-Reported Smoking, Urine Cotinine, and Risk of Cardiovascular Disease: Findings From the PREVEND (Prevention of Renal and Vascular End-Stage Disease) Prospective Cohort Study

  2018cites this paper
• Self‐Reported Smoking, Urine Cotinine, and Risk of Cardiovascular Disease: Findings From the PREVEND (Prevention of Renal and Vascular End‐Stage Disease) Prospective Cohort Study

  2018cites this paper
• S. J. L. (2018). Plasma neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease: Findings from the PREVEND

  2018cites this paper
• Plasma neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease: Findings from the PREVEND prospective cohort study.

  2018cites this paper
• Soluble Vascular Cell Adhesion Molecules May be Protective of Future Cardiovascular Disease Risk: Findings from the PREVEND Prospective Cohort Study

  2017cites this paper
• The inverse association of HDL-cholesterol with future risk of hypertension is not modified by its antioxidant constituent, paraoxonase-1: The PREVEND prospective cohort study.

  2017cites this paper
• Chapter 5 – Reverse Cholesterol Transport in HDL Metabolism: Relevance to Atherosclerosis Progression and Cardiovascular Diseases

  2017cites this paper
• Circulating Total Bilirubin and Future Risk of Hypertension in the General Population: The Prevention of Renal and Vascular End‐Stage Disease (PREVEND) Prospective Study and a Mendelian Randomization Approach

  2017cites this paper
• Lipids and apolipoproteins in cardiovascular disease

  2016cites this paper
• Cholesteryl ester transfer protein inhibitors: challenges and perspectives

  2016cites this paper
• Re-evaluation of cholesteryl ester transfer protein function in atherosclerosis based upon genetics and pharmacological manipulation

  2016cites this paper
• Serum paraoxonase-1 activity and risk of incident cardiovascular disease: The PREVEND study and meta-analysis of prospective population studies.

  2016cites this paper
• Discovery of High-Density Lipoprotein Gene Targets from Classical Genetics to Genome-Wide Association Studies

  2016cites this paper
• Circulating Total Bilirubin and Risk of Incident Cardiovascular Disease in the General Population

  2015cites this paper
• Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk?: CETP as a Target to Lower CVD Risk Suspension of Disbelief?

  2015cites this paper
• Low-Normal Thyroid Function and Novel Cardiometabolic Biomarkers

  2015cites this paper
• Serum Alkaline Phosphatase and Risk of Incident Cardiovascular Disease: Interrelationship with High Sensitivity C-Reactive Protein

  2015cites this paper
• Increased large VLDL particles confer elevated cholesteryl ester transfer in diabetes

  2015cites this paper
• Phospholipid transfer protein activity and incident type 2 diabetes mellitus.

  2015cites this paper
• Circulating gamma glutamyltransferase and prediction of cardiovascular disease.

  2015cites this paper
• Is Cholesteryl Ester Transfer Protein Inhibition an Effective Strategy to Reduce Cardiovascular Risk? CETP as a Target to Lower CVD Risk: Suspension of Disbelief? C oNTRoVERSIES I N C ARDIoVASCULAR M EDICINE

  2015cites this paper
• Improved plasma cholesterol efflux capacity from human macrophages in patients with hyperalphalipoproteinemia.

  2014cites this paper
• HDL-targeted therapies: progress, failures and future

  2014cites this paper
• Combined Phytosterol and Fish Oil Therapy for Lipid Lowering and Cardiovascular Health

  2014cites this paper
• Reverse Cholesterol Transport in HDL Metabolism: Modulation of Structural and Functional Features of HDL Particles

  2014cites this paper
• Future of cholesteryl ester transfer protein inhibitors.

  2014cites this paper
• The inverse association of incident cardiovascular disease with plasma bilirubin is unaffected by adiponectin.

  2014cites this paper
• HDL-C: does it matter? An update on novel HDL-directed pharmaco-therapeutic strategies.

  2013cites this paper
• Monogenic causes of elevated HDL cholesterol and implications for development of new therapeutics

  2013cites this paper
• Plasma lipid transfer proteins and cardiovascular disease. The Framingham Heart Study.

  2013cites this paper
• Herbal Supplements or Herbs in Heart Disease

  2013cites this paper
• Cholesteryl Ester Transfer Protein in Patients with Rheumatoid Arthritis

  2013cites this paper
• Les inhibiteurs de la CETP

  2012cites this paper
• HOMA-IR and non-HDL-C as predictors of high cholesteryl ester transfer protein activity in patients at risk for type 2 diabetes.

  2012cites this paper
• Actividad de la proteína transportadora de ésteres de colesterol. Polimorfismos del gen en pacientes colombianos con enfermedad coronaria

  2012cites this paper
• The plasma leptin/adiponectin ratio predicts first cardiovascular event in men: a prospective nested case-control study.

  2012influential citation
• CETP Pharmacological Manipulation Transforming Human into Mouse: Is this Still a Viable Hypothesis?

  2012cites this paper
• Impact of unhealthy lifestyle behaviors and obesity on cholesteryl ester transfer protein among adolescent males.

  2011cites this paper
• High plasma cholesteryl ester transfer but not CETP mass predicts incident cardiovascular disease: a nested case-control study.

  2011cites this paper
• Low levels of high-density lipoprotein cholesterol due to lecithin:cholesterol acyltransferase mutations increase carotid atherosclerosis.

  2011cites this paper
• Novel HDL-directed pharmacotherapeutic strategies

  2011cites this paper
• Cholesteryl ester transfer protein inhibition in cardiovascular risk management: ongoing trials will end the confusion.

  2011cites this paper
• Cholesteryl ester transfer protein, low density lipoprotein particle size and intima media thickness in patients with coronary heart disease.

  2011cites this paper
• Human Cholesteryl Ester Transfer Protein in Human HDL Metabolism

  2010cites this paper
• High plasma lecithin:cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: possible attenuation of cardioprotection associated with high HDL cholesterol.

  2010cites this paper
• The Role of Cholesteryl Ester Transfer Protein (CETP) in HDL Metabolism

  2010cites this paper
• High-density lipoprotein therapeutics and cardiovascular prevention.

  2010cites this paper
• Plasma cholesteryl ester transfer protein (CETP) in relation to human pathophysiology

  2010cites this paper
• On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study).

  2010cites this paper
• Altered composition of triglyceride-rich lipoproteins and coronary artery disease in a large case-control study.

  2009cites this paper
• Beyond blood lipids: phytosterols, statins and omega-3 polyunsaturated fatty acid therapy for hyperlipidemia.

  2009cites this paper
• Lipid transfer proteins : consequences for cellular cholesterol efflux and cardiovascular risk in diabetes mellitus

  2009cites this paper
• Is high HDL cholesterol always good?

  2009cites this paper
• Association of Circulating Cholesteryl Ester Transfer Protein Activity With Incidence of Cardiovascular Disease in the Community

  2009cites this paper
• CETP antagonism versus agonism in cardiovascular prevention and plaque regression

  2009cites this paper
• Plasma Lipid Transfer Enzymes in Non-Diabetic Lean and Obese Men and Women

  2009cites this paper
• Viability of developing CETP inhibitors.

  2008cites this paper
• Genetics of CETP Deficiency-Associated Cardiovascular Risk

  2008influential citation
• Cholesteryl ester transfer protein (CETP) inhibitors: is there life after torcetrapib?

  2008cites this paper
• Common variation in the CETP gene and the implications for cardiovascular disease and its treatment: an updated analysis.

  2008cites this paper
• Effects of pistachios on cardiovascular disease risk factors and potential mechanisms of action: a dose-response study.

  2008cites this paper
• Raising HDL cholesterol for cardiovascular disease prevention: Is this still feasible?

  2008cites this paper
• COMMENT s the Cholesteryl ster Transfer Protein roatherogenic or ntiatherogenic in Humans ? *

  2007cites this paper
• CETP inhibition in cardiovascular risk management: a critical appraisal

  2007cites this paper